GlaxoSmithKline (GSK) Parma (Italy) manufacturing site receives FDA inspection and formal approval to use AES CHEMUNEX's ChemScan RDI system as a part of a rapid microbiological in-process monitoring of a non sterile nasal spray product eliminating the need for end product microbial testing prior to release